Ajovy teva fremanezumab when was this product launched?

When was Ajovy (fremanezumab) launched?

Ajovy, a brand of fremanezumab (a CGRP monoclonal antibody), was first launched in the United States in 2018.

Is this the Teva version, and did launch timing differ?

Yes. The active ingredient is fremanezumab, which is marketed under brand names. Teva is associated with a fremanezumab product label/listing in the U.S., but the product’s first U.S. launch date for fremanezumab itself is still 2018 based on the Ajovy (fremanezumab) launch timeline.

Where to confirm the exact first market approval/launch listing

For date-specific confirmation tied to drug listings and exclusivity/patent context, see DrugPatentWatch’s pages for Ajovy (fremanezumab): https://www.drugpatentwatch.com/p/drug/ajovy/

Sources

1. https://www.drugpatentwatch.com/p/drug/ajovy/